Baxter suspends HemAssist in Europe

Article Abstract:

Baxter International Inc., based in Deerfield, IL, suspended a European trial of HemAssist, a blood substitute, following its conclusion that the product has no advantages over donated blood. The suspension leaves the company with a $110-million Swiss facility, which will have no product to produce. The company ended its clinical trial in the US after finding that more people died with the product compared to the group that received donated blood. HemAssist has long been targeted by the company as a potential blockbuster product and has invested around $500 million for its development.

Comment:

Suspends European trial of HemAssist, a blood substitute, following conclusion that product has no advantages over donated blood

United States, Biological Product (except Diagnostic) Manufacturing, Blood Plasma & Products, Baxter International Inc. (Deerfield, Illinois), Article

---

Glaxo to announce discovery of genes behind three diseases; breakthroughs in migraine, psoriasis, diabetes meant to shake up industry; Dr. Roses points the way

Article Abstract:

Glaxo Wellcome PLC plans to announce on Oct 19, 1999 that it has come close to identifying the genes that make people susceptible to migraines, psoriasis, and diabetes. Glaxo's co-director of exploratory science, Dr. Allen Roses will release information about the 3 genes before publishing the research in a peer-reviewed scientific journal, a decision which is expected to be controversial. Glaxo has not yet filed patents on the discoveries of the migraine, psoriasis, and diabetes genes, which were identified using single nucleotide polymorphism technology.

United Kingdom, Science & research, Pharmaceutical Preparation Manufacturing, Antidiabetic Preparations, Antipsoriatic Agents, Research, Planning, Pharmaceutical industry, Hypoglycemic agents, Glaxo Wellcome PLC, Gene therapy, Roses, Allen

---

Ugly in the air: Boeing's new plane gets gawks, stares

Article Abstract:

Boeing Co. of the United States is developing a new offering, the Large Cargo Freighter. The cargo carrier is a standard 747 that has been overhauled and is considered an "ugly duckling." Upon completion of testing it will be repainted white with a blue tail.

Aircraft, Aircraft industry, Boeing Co., BA, Financial report, Large Cargo Freighter (Aircraft)

Similar abstracts:

• Abstracts: Market entry and priority of small and medium-sized enterprises in the software industry: an empirical analysis of cultural distance, geographic distance, and market size
• Abstracts: Isadore Sharp. Learning to love ROMI. The rise of Lenovo

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.